Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Low hemoglobin A1C increases the risk of disability in community-dwelling older non-diabetics adults
Authors
K.-I. Kim
S. Kim
K.-W. Kim
H.-C. Jang
C.-H. Kim
Ho Jun Chin
Publication date
01-03-2016
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 3/2016
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-015-0583-z

Other articles of this Issue 3/2016

The journal of nutrition, health & aging 3/2016 Go to the issue

OriginalPaper

Associations of buccal cell telomere length with daily intake of β-carotene or α-tocopherol are dependent on carotenoid metabolism-related gene polymorphisms in healthy Japanese adults

OriginalPaper

Primary sarcopenia in older people with normal nutrition

OriginalPaper

The healthy core metabolism: A new paradigm for primary preventive nutrition

OriginalPaper

Associations of low muscle mass and the metabolic syndrome in Caucasian and Asian middle-aged and older adults

OriginalPaper

Influence of thoracic aortic inflammation and calcifications on arterial stiffness and cardiac function in older subjects

OriginalPaper

Serum cholesterol levels within the high normal range are associated with better cognitive performance among Chinese elderly
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits